Abstract
Serology has provided valuable diagnostic and epidemiological data on antibody responses to SARS-CoV-2 in diverse patient cohorts. Deployment of high content, multiplex serology platforms across the world, including in low and medium income countries, can accelerate longitudinal epidemiological surveys. Here we report multiSero, an open platform to enable multiplex serology with up to 48 antigens in a 96-well format. The platform consists of three components: ELISA-array of printed proteins, a commercial or home-built plate reader, and modular python software for automated analysis (pysero). We validate the platform by comparing antibody titers against the SARS-CoV-2 Spike, receptor binding domain (RBD), and nucleocapsid (N) in 114 sera from COVID-19 positive individuals and 87 pre-pandemic COVID-19 negative sera. We report data with both a commercial plate reader and an inexpensive, open plate reader (nautilus). Receiver operating characteristic (ROC) analysis of classification with single antigens shows that Spike and RBD classify positive and negative sera with the highest sensitivity at a given specificity. The platform distinguished positive sera from negative sera when the reactivity of the sera was equivalent to the binding of 1 ng mL−1 RBD-specific monoclonal antibody. We developed normalization and classification methods to pool antibody responses from multiple antigens and multiple experiments. Our results demonstrate a performant and accessible pipeline for multiplexed ELISA ready for multiple applications, including serosurveillance, identification of viral proteins that elicit antibody responses, differential diagnosis of circulating pathogens, and immune responses to vaccines.
- multiplex serology
- automated analysis
- accessible technology
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT04362150
Funding Statement
J.R.B, E.W, S-M.G, J.F, B.B.C, I.E.I, M.L.F, W.W, C.M.T, K.M.M, M.P, B.G, J.E.P, S.B.M are supported by the Chan Zuckerberg Biohub. M.L.F was also supported by the Knight-Hennessy Scholarship and a Graduate Research Fellowship from the National Science Foundation. H.L was supported by Bio-X Stanford Interdisciplinary Graduate Fellowship. This research was supported by the Chan Zuckerberg Biohub and NIH/NIAID 3R01AI141003-03S1 (to TJ Henrich).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
COVID-19 positive sera were collected during the LIINC study(https://www.liincstudy.org, NCT04362150), which was approved by the UCSF Institutional Review Board (IRB). The negative pool used in Fig.3A-B was made of sera collected under a study approved by UCSF IRB (10-03852). All subjects provided written informed consent. Authors received de-identified pre-pandemic COVID-19 negative sera from the New York Blood Center (NYBC). These samples were collected from volunteer blood donors, who consented to the use of donated blood for transfusion and research.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The images of SARS-CoV-2 ELISA-array assayed with 189 sera, spread over 6 plates, are available publicly via google drive (https://bit.ly/34ZjdtQ). The python code to analyze this data is available from this GitHub repository (https://github.com/czbiohub/pysero). The repository also includes code and instructions to reproduce fig. 4 from above images.
